Sep 12, 2023 2:00 pm EST

Click HERE to register



GLP-1 RA weight loss drugs continue to be associated with new side effects and injuries. Most recently, very concerning reports of severe and sometimes permanent cases of gastroparesis are ever increasing. Please join our panel to learn all the ins and outs of this evolving litigation, including:

  • The history of GLP-1 RA class drugs and FDA approval
  • Rampant off-label marketing and promotion
  • What is gastroparesis? Who is at risk? How many victims are there?
  • Status of evolving litigation
  • Next steps